Your session is about to expire
← Back to Search
Dietary Supplement
Extended Longevity Supplements for Aging
Phase 2
Waitlist Available
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing will compare the change in results after completion of intervention with baseline
Awards & highlights
Study Summary
This trial is testing a new protocol to see if it can help people live longer, healthier lives by measuring its effect on epigenetic age.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ testing will compare the change in results after completion of intervention with baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing will compare the change in results after completion of intervention with baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Epigenetic Age
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExtractsExperimental Treatment1 Intervention
The ingredients found in these serums are all naturally occurring ingredients extracted from a variety of plant species: Pinetonal, Thyvolve, Telogenic, Sentophagy, Inflasolve, Stemegenis, and CMEnhance
Find a Location
Who is running the clinical trial?
TruDiagnosticLead Sponsor
11 Previous Clinical Trials
471 Total Patients Enrolled
8 Trials studying Aging
361 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a serious heart or stroke condition that is not stable or under control.You had a mini-stroke within the past 6 months.You have not had a viral illness in the past that could become active again if your immune system is weakened.Your immune system must be working properly and you should not have any known immune system problems.You have any other medical condition, mental health disorder, or addiction that the doctor thinks would make it unsafe for you to take part in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Extracts
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger